Post by Nadica (She/Her) on Sept 26, 2024 3:04:41 GMT
Long COVID: what do we know now and what are the challenges ahead? - Published Sept 23, 2024
Introduction
The first case of severe acute respiratory syndrome coronavirus 2 was reported in Wuhan, China, in December 2019; the first case in the UK was reported in January 2020. By March 2020, reports were emerging that some coronavirus disease 2019 (COVID-19) survivors were left with persisting health problems rather than making a complete recovery. These people are commonly referred to as having Long COVID or post-COVID-19 condition. The UK government has invested over £50 million in Long COVID research1 and over 200 symptoms associated with Long COVID, in adults and in children and young people (CYP), have been identified.2,3 Yet, there is stark heterogeneity in the literature regarding the implementation of, and approach to, treating Long COVID. The purpose of this commentary is to reflect on what we know and what we need to know about Long COVID and to provide a springboard for suggestions on how to be better prepared for future pandemics.
Introduction
The first case of severe acute respiratory syndrome coronavirus 2 was reported in Wuhan, China, in December 2019; the first case in the UK was reported in January 2020. By March 2020, reports were emerging that some coronavirus disease 2019 (COVID-19) survivors were left with persisting health problems rather than making a complete recovery. These people are commonly referred to as having Long COVID or post-COVID-19 condition. The UK government has invested over £50 million in Long COVID research1 and over 200 symptoms associated with Long COVID, in adults and in children and young people (CYP), have been identified.2,3 Yet, there is stark heterogeneity in the literature regarding the implementation of, and approach to, treating Long COVID. The purpose of this commentary is to reflect on what we know and what we need to know about Long COVID and to provide a springboard for suggestions on how to be better prepared for future pandemics.